Human Xtensions (Israel) Performance
| HUMX Stock | ILA 29.10 0.20 0.69% |
The company retains a Market Volatility (i.e., Beta) of 0.32, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Human Xtensions' returns are expected to increase less than the market. However, during the bear market, the loss of holding Human Xtensions is expected to be smaller as well. At this point, Human Xtensions has a negative expected return of -0.99%. Please make sure to check out Human Xtensions' total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if Human Xtensions performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Human Xtensions has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Human |
Human Xtensions Relative Risk vs. Return Landscape
If you would invest 4,990 in Human Xtensions on September 29, 2024 and sell it today you would lose (2,080) from holding Human Xtensions or give up 41.68% of portfolio value over 90 days. Human Xtensions is generating negative expected returns and assumes 5.4725% volatility on return distribution over the 90 days horizon. Simply put, 48% of stocks are less volatile than Human, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Human Xtensions Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Human Xtensions' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Human Xtensions, and traders can use it to determine the average amount a Human Xtensions' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.181
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HUMX |
Estimated Market Risk
| 5.47 actual daily | 48 52% of assets are more volatile |
Expected Return
| -0.99 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Human Xtensions is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Human Xtensions by adding Human Xtensions to a well-diversified portfolio.
Human Xtensions Fundamentals Growth
Human Stock prices reflect investors' perceptions of the future prospects and financial health of Human Xtensions, and Human Xtensions fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Human Stock performance.
| Return On Equity | -0.5 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (14.93) % | |||
| Current Valuation | (47.61 M) | |||
| Shares Outstanding | 26.76 M | |||
| Price To Book | 0.27 X | |||
| Price To Sales | 6.20 X | |||
| Revenue | 3.12 M | |||
| EBITDA | (45.95 M) | |||
| Cash And Equivalents | 148.31 M | |||
| Cash Per Share | 5.56 X | |||
| Total Debt | 7.55 M | |||
| Debt To Equity | 0.05 % | |||
| Book Value Per Share | 2.67 X | |||
| Cash Flow From Operations | (27.26 M) | |||
| Earnings Per Share | (2.01) X | |||
About Human Xtensions Performance
By analyzing Human Xtensions' fundamental ratios, stakeholders can gain valuable insights into Human Xtensions' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Human Xtensions has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Human Xtensions has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
It offers HandX, a handheld medical device for use in laparoscopic procedures. The company was founded in 2012 and is based in Netanya, Israel. HUMAN XTENSIONS operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 58 people.Things to note about Human Xtensions performance evaluation
Checking the ongoing alerts about Human Xtensions for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Human Xtensions help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Human Xtensions generated a negative expected return over the last 90 days | |
| Human Xtensions has high historical volatility and very poor performance | |
| Human Xtensions has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.12 M. Net Loss for the year was (28.54 M) with profit before overhead, payroll, taxes, and interest of 1.62 M. | |
| Human Xtensions has accumulated about 148.31 M in cash with (27.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.56. | |
| Roughly 55.0% of the company shares are held by company insiders |
- Analyzing Human Xtensions' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Human Xtensions' stock is overvalued or undervalued compared to its peers.
- Examining Human Xtensions' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Human Xtensions' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Human Xtensions' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Human Xtensions' stock. These opinions can provide insight into Human Xtensions' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Human Stock analysis
When running Human Xtensions' price analysis, check to measure Human Xtensions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Human Xtensions is operating at the current time. Most of Human Xtensions' value examination focuses on studying past and present price action to predict the probability of Human Xtensions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Human Xtensions' price. Additionally, you may evaluate how the addition of Human Xtensions to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |